Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" ABCD3 "PMP70, PXMP1, ZWS2" ENSG00000117528 "ATP binding cassette subfamily D member 3" P28288 1 94418455-94518666 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032026, HPA032027, CAB032516, CAB075749" Enhanced Enhanced Peroxisomes NA NA Peroxisomes "CAB032516: AB_2257637, CAB075749: AB_2665755, HPA032026: AB_2674117, HPA032027: AB_10602103" "unprognostic (1.41e-2)" "unprognostic (3.21e-1)" "prognostic favorable (1.16e-5)" "unprognostic (1.92e-1)" "unprognostic (5.42e-2)" "unprognostic (1.56e-1)" "unprognostic (1.94e-2)" "unprognostic (2.54e-2)" "unprognostic (5.10e-2)" "unprognostic (3.20e-2)" "unprognostic (1.01e-1)" "unprognostic (9.12e-2)" "prognostic favorable (4.84e-5)" "unprognostic (5.45e-2)" "unprognostic (6.20e-2)" "unprognostic (3.41e-1)" "unprognostic (1.29e-1)" 8.9 14.2 13.1 9.5 13.3 10.3 16.8 11.2 12.8 11.8 21.2 14.9 24.9 21.4 9.8 14.6 15.4 10.0 17.3 16.0 12.7 10.3 29.3 60.6 11.2 9.9 13.2 10.4 8.1 16.7 18.3 14.6 11.2 14.3 11.0 20.1 21.4 13.2 24.0 12.9 17.1 21.7 10.8 16.5 7.6 20.8 10.2 12.7 46.5 13.7 10.8 9.9 11.8 11.1 3.1 8.4 3.9 6.2 8.0 7.4 4.2 28.2 13.3 13.7 13.1 10.6 11.7 20.4 14.8 11.5 17.0 19.0 41.4 8.9 17.5 19.2 18.7 18.3 20.8 15.8 19.1 24.0 14.0 13.6 19.9 19.6 35.9 10.3 17.6 6.2 9.8 10.8 19.8 7.6 11.1 10.4 16.7 8.8 10.5 17.6 3.9 29.6 9.3 15.8 21.7 18.9 16.7 28.6 6.8 16.9 43.3 10.4 17.1 25.6 27.2 19.2 10.9 10.0 14.7 10.3 12.7 18.4 22.2 19.6 6.0 5.6 17.1 9.9 9.0 5.9 0.3 5.3 3.9 6.5 6.2 6.1 2.8 5.9 7.4 8.4 3.1 7.1 6.9 1.3 8.0 5.2 2.2 6.5 4.2 13.1 13.3 11.2 12.8 12.7 10.3 13.2 10.4 14.3 12.7 32.8 39.0 10.4 16.3 20.7 25.9 36.4 63.7 30.8 25.0 40.1 21.6 22.7 19.9 19.9 5.4 12.0 62.4 0.0 38.4 9.6 17.3 22.1 27.6 99.9 10.1 31.8 38.2 20.3 21.6 6.2 12.7 12.6 15.1 2.8 38.1 85.8 29.7 28.1 23.0 56.2 22.8 19.4 12.3 10.4 23.7 29.6 12.8 10.5 32.8 20.0 ACAA1 ENSG00000060971 "Acetyl-CoA acyltransferase 1" P09110 3 38103129-38137242 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 152.1" "Cell type enhanced" "Detected in all" 9 "Hepatocytes: 651.0;Proximal tubular cells: 601.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 51.9;SK-BR-3: 82.5" "Low region specificity" "Detected in all" "HPA006764, HPA007244" Enhanced Supported Peroxisomes NA NA 4300000 Peroxisomes "HPA006764: AB_1078085, HPA007244: AB_1078084" "prognostic favorable (3.00e-4)" "unprognostic (5.57e-2)" "unprognostic (4.54e-2)" "prognostic favorable (7.53e-4)" "unprognostic (2.63e-1)" "prognostic favorable (1.23e-4)" "unprognostic (9.35e-3)" "unprognostic (2.91e-2)" "unprognostic (8.11e-2)" "unprognostic (2.22e-1)" "unprognostic (2.24e-1)" "unprognostic (4.90e-1)" "prognostic favorable (6.99e-9)" "unprognostic (1.72e-1)" "unprognostic (1.99e-1)" "unprognostic (2.50e-2)" "unprognostic (1.65e-2)" 9.5 12.7 11.0 5.6 11.9 9.6 10.2 8.1 14.3 6.7 16.1 12.5 10.6 23.4 4.9 13.3 12.1 4.6 16.0 17.7 10.2 8.9 48.7 152.1 8.2 5.9 14.0 9.4 5.0 19.2 7.4 5.9 6.8 11.0 13.4 12.4 7.3 11.5 9.4 9.8 6.2 23.8 4.8 12.7 10.0 8.5 4.4 10.9 5.7 9.3 10.1 10.2 9.4 7.0 9.2 47.0 32.8 45.2 17.8 19.3 18.8 8.1 8.9 3.0 9.5 13.1 7.7 10.6 7.5 10.9 8.6 8.2 11.9 9.2 4.8 5.4 12.0 4.2 5.4 8.2 12.7 4.7 7.0 8.5 6.2 7.9 33.7 8.5 14.3 14.0 14.2 9.1 7.4 5.3 5.4 11.6 11.8 5.8 5.7 9.5 10.6 13.8 10.2 3.2 51.9 10.8 3.1 5.8 8.1 24.2 24.2 2.6 4.1 7.3 82.5 5.2 4.4 8.5 11.5 8.4 5.2 5.0 10.4 10.3 7.6 4.8 3.8 8.5 12.5 8.3 15.3 29.9 32.8 13.6 40.7 11.4 9.2 13.1 13.3 47.0 8.7 13.0 12.1 20.4 17.8 45.2 27.7 19.3 18.8 11.0 11.9 8.1 14.3 10.2 8.9 14.0 9.4 11.0 10.9 38.7 31.4 45.5 55.9 29.7 37.5 2.4 109.5 17.4 19.4 62.8 13.7 77.1 140.9 89.4 3.0 25.4 292.3 23.3 69.3 52.5 32.7 64.1 18.5 651.0 74.1 7.9 52.9 34.4 86.5 6.4 33.1 68.8 55.6 86.6 63.2 33.0 78.8 122.8 31.1 601.4 14.2 32.3 25.8 17.5 11.7 31.0 83.1 42.0 60.0 69.8 ACBD5 "DKFZp434A2417, KIAA1996" ENSG00000107897 "Acyl-CoA binding domain containing 5" Q5T8D3 10 27195214-27242130 "Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011861, HPA012145" Enhanced Enhanced Peroxisomes NA NA Peroxisomes "HPA011861: AB_1844493, HPA012145: AB_1844494" "prognostic unfavorable (3.33e-4)" "unprognostic (4.93e-1)" "unprognostic (3.68e-1)" "unprognostic (1.34e-1)" "unprognostic (6.21e-2)" "unprognostic (5.98e-3)" "unprognostic (9.87e-2)" "unprognostic (3.42e-2)" "unprognostic (2.69e-1)" "unprognostic (3.66e-1)" "unprognostic (1.11e-1)" "unprognostic (4.46e-2)" "prognostic favorable (4.68e-5)" "unprognostic (7.91e-3)" "unprognostic (1.71e-1)" "unprognostic (3.63e-2)" "unprognostic (3.37e-3)" 9.2 15.7 25.7 7.1 21.5 7.7 7.4 13.7 21.3 8.4 15.5 17.7 9.1 23.0 5.6 6.1 7.2 7.4 9.0 23.0 23.0 21.1 22.8 44.7 8.5 7.6 27.4 14.0 6.3 6.5 18.9 6.0 7.8 21.3 9.2 12.6 12.9 7.2 10.2 15.8 9.3 24.6 5.3 31.0 8.4 12.2 10.8 20.9 5.7 16.6 7.6 7.6 9.7 5.8 7.0 12.9 11.5 14.0 9.0 16.6 7.4 12.5 38.2 8.2 9.2 10.0 9.2 10.4 15.7 6.3 14.4 17.4 9.5 19.7 5.6 13.8 11.1 11.9 10.2 12.2 8.3 12.3 12.7 12.0 7.7 11.4 7.2 11.6 5.0 10.5 8.9 9.2 12.0 6.9 12.6 10.5 8.8 6.4 8.5 18.6 9.5 10.3 4.2 6.5 17.6 4.9 8.9 21.7 9.7 23.1 11.2 11.7 23.2 17.8 19.4 9.2 10.0 9.5 5.7 14.7 14.0 7.7 21.9 12.6 10.0 13.6 10.0 14.2 12.3 6.0 9.4 13.1 10.5 16.6 12.9 16.4 7.0 8.3 13.0 12.9 7.0 5.7 12.0 11.5 9.0 14.0 9.3 7.3 7.4 25.7 21.5 13.7 19.2 23.0 21.1 27.4 14.0 21.3 20.9 23.8 25.1 11.0 4.6 8.7 30.3 79.5 12.7 45.5 30.7 29.6 23.6 8.2 28.2 18.4 34.5 13.7 22.7 0.0 14.1 10.2 9.7 11.6 11.6 44.5 17.0 22.3 9.8 11.1 23.9 11.7 15.3 19.9 20.3 19.0 32.4 46.4 15.5 24.9 15.6 36.0 38.2 19.4 9.2 39.6 7.5 13.6 8.7 19.5 24.7 7.1 ACOX1 PALMCOX ENSG00000161533 "Acyl-CoA oxidase 1" Q15067 17 75941507-75979363 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 95.6" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 185.5;Hepatocytes: 244.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 22.9;neutrophil: 38.6" "Lineage enriched" "Detected in all" 7 "granulocytes: 38.6" "Cell line enhanced" "Detected in all" "BEWO: 35.3;RT4: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021094, HPA021192, HPA021195, HPA028759" Approved Approved Nucleoli,Peroxisomes NA NA 160000 Peroxisomes Nucleoli "CAB021094: AB_10261667, HPA021192: AB_1844527, HPA021195: AB_1844528, HPA028759: AB_10601352" "unprognostic (7.47e-2)" "unprognostic (3.69e-1)" "unprognostic (1.25e-3)" "unprognostic (1.36e-1)" "unprognostic (7.49e-2)" "unprognostic (8.14e-2)" "unprognostic (3.75e-2)" "unprognostic (4.95e-2)" "unprognostic (1.61e-1)" "unprognostic (5.33e-2)" "unprognostic (1.25e-1)" "unprognostic (3.38e-2)" "prognostic favorable (5.25e-7)" "unprognostic (3.39e-1)" "unprognostic (2.41e-2)" "unprognostic (1.72e-1)" "unprognostic (4.46e-2)" 21.8 12.9 8.8 8.3 10.2 4.2 13.6 6.4 9.8 6.4 26.5 8.2 9.6 31.0 6.6 6.7 19.5 6.0 12.3 16.0 8.3 7.9 20.8 95.6 9.2 7.5 8.2 8.3 7.6 28.7 9.8 8.9 13.6 7.8 9.5 14.3 11.3 9.5 9.1 18.3 13.4 53.1 7.9 6.7 7.2 13.6 6.2 6.3 7.1 9.1 11.4 10.6 10.6 7.9 1.6 3.3 38.6 5.8 2.1 2.7 2.2 5.4 7.7 2.5 3.8 13.3 5.6 35.3 4.0 4.0 4.8 5.5 5.4 9.0 3.1 4.3 6.8 4.5 3.3 10.7 4.2 7.6 2.8 3.2 4.0 4.4 17.7 7.2 3.4 2.6 9.3 3.3 5.4 3.6 5.1 12.0 4.3 4.1 3.1 5.3 16.1 7.6 2.5 1.9 13.5 6.7 4.2 7.7 3.6 8.1 47.5 3.1 4.6 11.4 17.8 3.8 8.7 10.9 3.9 7.9 6.7 4.9 5.4 3.8 5.1 3.5 1.2 3.9 3.2 3.9 22.9 5.8 1.6 2.1 4.5 2.7 1.6 2.0 2.7 3.3 1.6 2.4 2.3 38.6 2.1 2.8 2.9 2.6 2.2 8.8 10.2 6.4 9.8 8.3 7.9 8.2 8.3 7.8 6.3 26.8 20.6 3.0 13.1 11.9 23.8 38.6 48.4 14.7 18.2 22.7 21.6 32.5 18.3 19.8 8.4 14.6 185.5 23.3 35.6 39.3 17.0 27.2 16.2 244.8 23.1 17.5 33.1 22.1 31.8 6.5 27.6 19.9 13.5 25.2 35.0 64.2 31.5 87.7 44.2 74.6 28.4 0.0 16.4 5.6 10.7 26.5 36.2 10.2 32.4 22.6 ACOX3 ENSG00000087008 "Acyl-CoA oxidase 3, pristanoyl" O15254 4 8366282-8440723 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Syncytiotrophoblasts: 62.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035840, HPA035841" Uncertain Approved Peroxisomes NA NA Peroxisomes "HPA035840: AB_10696514, HPA035841: AB_10671940" "unprognostic (3.07e-2)" "unprognostic (5.51e-2)" "unprognostic (1.12e-1)" "prognostic favorable (2.16e-4)" "unprognostic (5.52e-2)" "unprognostic (1.81e-3)" "unprognostic (2.21e-1)" "unprognostic (3.37e-2)" "unprognostic (2.27e-1)" "unprognostic (4.43e-2)" "unprognostic (4.81e-1)" "unprognostic (1.39e-1)" "unprognostic (1.46e-2)" "unprognostic (3.58e-2)" "unprognostic (2.84e-1)" "unprognostic (1.69e-1)" "unprognostic (2.65e-1)" 9.6 12.0 9.9 7.4 10.9 5.0 15.5 11.7 12.8 12.2 9.9 11.5 11.2 10.8 10.7 12.3 32.0 9.2 7.4 20.6 9.0 6.7 8.3 18.0 8.9 7.4 10.3 8.4 9.8 15.4 10.0 14.8 28.9 10.2 13.4 8.0 12.0 19.1 11.2 8.2 14.8 10.5 18.6 7.2 7.6 12.7 5.0 11.6 9.0 11.5 7.4 14.2 14.8 16.0 4.6 16.8 2.6 12.0 7.3 8.0 6.9 6.3 6.9 7.8 10.3 8.4 14.3 12.7 8.0 11.1 13.8 12.0 3.4 8.5 8.5 8.7 16.4 18.6 3.9 3.3 10.4 10.7 2.9 3.3 3.7 5.8 10.5 13.9 7.4 7.0 14.3 9.0 12.3 4.8 9.9 16.2 9.5 4.9 7.8 11.8 5.8 7.9 11.0 4.3 8.1 12.0 8.4 12.8 10.1 8.4 8.9 3.8 8.7 10.3 5.3 5.3 6.7 5.3 10.7 15.6 13.6 4.4 5.5 8.4 5.9 3.9 3.8 17.3 9.4 8.6 0.0 10.6 2.6 5.2 12.0 5.4 4.6 6.1 6.6 14.0 4.5 5.6 5.8 2.5 7.3 10.6 16.8 8.0 6.9 9.9 10.9 11.7 12.8 9.0 6.7 10.3 8.4 10.2 11.6 6.0 5.1 6.4 6.8 3.9 8.6 8.5 7.6 4.0 4.5 10.4 31.4 19.8 3.3 13.9 2.2 3.9 11.8 0.0 11.9 8.2 5.8 7.8 0.0 9.9 8.9 1.6 1.7 5.5 3.2 2.1 6.4 4.2 5.0 8.2 4.9 4.1 15.1 9.9 10.6 5.1 15.8 0.0 6.2 1.2 1.9 5.1 62.4 5.0 6.7 10.0 AGPS "ADAP-S, ADAS, ADHAPS, ADPS, ALDHPSY" ENSG00000018510 "Alkylglycerone phosphate synthase" O00116 2 177392644-177559299 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Cataract, Disease mutation, Dwarfism, Rhizomelic chondrodysplasia punctata" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 201.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030209, HPA030210, HPA030211" Supported Supported Peroxisomes "Intracellular and membrane" NA NA 9300 Peroxisomes "HPA030209: AB_10600634, HPA030210: AB_10600202, HPA030211: AB_10602195" "unprognostic (7.10e-2)" "unprognostic (1.20e-2)" "unprognostic (1.76e-3)" "unprognostic (3.79e-2)" "unprognostic (8.34e-2)" "unprognostic (3.78e-2)" "prognostic unfavorable (8.62e-6)" "unprognostic (1.23e-2)" "unprognostic (7.23e-2)" "unprognostic (5.41e-2)" "prognostic unfavorable (8.35e-4)" "unprognostic (7.74e-2)" "prognostic favorable (9.45e-4)" "unprognostic (7.18e-2)" "unprognostic (3.46e-1)" "unprognostic (4.94e-3)" "unprognostic (1.92e-2)" 22.9 17.7 13.5 21.2 14.9 28.3 17.1 14.9 13.4 16.0 23.5 17.2 14.1 14.1 22.4 10.5 18.4 12.5 16.0 23.9 14.2 13.5 20.8 21.2 15.2 14.7 17.4 11.8 16.4 21.2 37.0 11.7 14.7 15.0 14.7 24.0 8.0 18.2 10.8 23.2 9.6 17.6 21.3 31.8 17.1 14.5 19.1 13.7 29.5 14.2 14.4 14.5 16.9 20.7 3.4 7.6 11.2 6.8 5.6 6.4 3.0 18.1 11.6 8.2 8.5 10.6 11.6 19.7 14.2 7.1 12.2 12.1 21.7 12.6 20.4 31.0 14.7 19.8 19.8 22.2 14.4 15.9 26.9 7.5 28.3 20.2 25.4 10.8 30.7 30.2 10.1 9.1 19.5 15.6 11.2 24.3 15.5 19.4 12.8 14.6 0.0 24.8 10.4 14.0 13.4 19.3 19.9 24.7 12.3 20.7 21.7 10.2 12.3 26.9 2.3 16.7 20.4 0.1 12.8 24.9 10.9 37.4 11.2 24.8 16.5 28.6 10.2 10.0 13.8 4.2 3.8 6.1 11.2 4.3 6.7 6.4 3.4 5.5 5.3 7.6 2.1 5.3 3.1 1.3 5.6 6.8 0.7 6.2 3.0 13.5 14.9 14.9 13.4 14.2 13.5 17.4 11.8 15.0 13.7 14.9 16.2 8.2 5.5 9.6 11.1 17.3 12.7 17.4 7.9 14.0 2.0 12.4 11.6 18.7 201.7 9.3 16.8 23.3 20.1 17.2 15.1 3.1 63.4 25.2 28.4 14.3 19.0 13.5 27.2 24.3 13.6 24.2 13.5 31.5 25.9 11.6 19.9 10.5 13.1 41.6 6.9 6.5 16.2 38.6 25.3 8.5 5.8 17.0 19.4 5.5 DECR2 "PDCR, SDR17C1" ENSG00000242612 "2,4-dienoyl-CoA reductase 2" Q9NUI1 16 401826-412487 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 68.2" "Cell type enhanced" "Detected in many" 6 "Hepatocytes: 103.3;Proximal tubular cells: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047631 Approved Peroxisomes,Microtubules NA NA Peroxisomes Microtubules "HPA047631: " "unprognostic (2.74e-2)" "unprognostic (3.84e-1)" "unprognostic (1.83e-1)" "unprognostic (4.44e-3)" "unprognostic (1.77e-1)" "unprognostic (7.45e-2)" "unprognostic (2.38e-2)" "unprognostic (1.17e-1)" "unprognostic (1.91e-1)" "unprognostic (3.02e-2)" "unprognostic (3.11e-2)" "unprognostic (3.38e-1)" "unprognostic (1.12e-1)" "unprognostic (3.40e-1)" "unprognostic (2.21e-1)" "unprognostic (1.94e-1)" "unprognostic (4.22e-3)" 5.7 10.8 3.2 4.3 4.0 3.5 4.0 3.8 5.0 2.9 10.2 2.7 5.0 14.2 4.0 7.3 4.1 2.5 7.8 4.4 2.8 2.3 16.9 68.2 4.3 3.9 2.0 3.0 2.6 9.7 1.8 2.6 2.3 2.0 4.1 2.4 3.0 6.2 5.6 15.9 2.9 14.4 5.1 1.9 1.9 5.9 4.1 1.8 1.2 1.7 4.3 2.9 2.7 2.2 3.3 9.5 0.4 6.1 2.7 5.1 3.9 1.1 11.1 1.4 6.6 1.3 3.0 4.2 3.4 2.5 2.9 3.0 7.0 7.6 3.8 7.3 4.2 1.7 2.5 1.1 2.8 0.4 8.4 3.6 0.9 5.4 16.6 8.7 3.4 5.4 4.3 2.1 1.9 2.4 3.3 3.6 4.4 2.3 3.5 2.4 11.6 1.9 4.7 4.1 4.2 5.8 4.5 0.5 6.9 2.9 2.9 2.9 4.5 6.4 7.2 3.7 0.5 10.3 4.2 7.5 2.5 2.7 3.5 2.6 5.0 3.9 1.6 3.4 5.1 8.1 0.0 6.1 0.4 3.6 5.6 2.5 2.8 2.2 2.4 6.5 3.3 5.1 3.0 0.3 2.7 4.5 9.5 1.7 3.9 3.2 4.0 3.8 5.0 2.8 2.3 2.0 3.0 2.0 1.8 11.9 14.4 4.2 8.0 3.4 2.0 7.0 17.8 12.0 9.1 19.2 0.0 28.2 33.2 28.8 1.8 5.8 56.4 46.7 34.2 4.7 8.9 4.3 12.7 103.3 11.0 3.2 12.0 6.7 6.7 5.5 6.1 5.3 5.0 15.4 26.4 5.8 28.8 35.1 6.3 98.2 2.7 0.0 6.2 1.8 5.7 5.3 10.5 2.2 34.3 2.7 ECI2 "ACBD2, DRS1, HCA88, PECI" ENSG00000198721 "Enoyl-CoA delta isomerase 2" O75521 6 4115689-4135597 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 102.3" "Cell type enhanced" "Detected in all" 8 "Distal tubular cells: 363.1;Proximal tubular cells: 504.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA022130, HPA031626" Enhanced Enhanced Peroxisomes,Mitochondria NA NA "Peroxisomes, Mitochondria" "HPA022130: AB_1855176, HPA031626: AB_2673965" "unprognostic (2.36e-1)" "unprognostic (1.76e-2)" "unprognostic (1.71e-2)" "unprognostic (1.04e-2)" "unprognostic (1.00e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.17e-3)" "unprognostic (4.97e-2)" "unprognostic (9.49e-2)" "unprognostic (3.95e-3)" "unprognostic (3.17e-2)" "unprognostic (5.75e-2)" "prognostic favorable (2.04e-6)" "unprognostic (1.40e-1)" "unprognostic (1.23e-1)" "unprognostic (8.45e-2)" "unprognostic (1.34e-1)" 17.9 29.2 13.2 7.3 17.4 4.5 17.0 8.9 9.5 15.7 18.0 10.7 14.9 16.2 15.2 26.2 10.6 12.7 12.4 32.1 10.3 11.1 56.8 102.3 7.4 8.9 13.3 7.2 19.0 59.2 8.9 17.2 11.1 10.3 14.6 14.0 13.3 9.0 10.5 45.7 5.6 22.7 10.3 11.9 10.1 23.2 11.9 9.3 13.3 17.7 26.6 7.5 12.6 8.9 20.6 25.1 7.0 16.2 25.5 27.7 16.7 17.8 9.7 16.3 35.3 20.5 30.5 2.0 25.3 25.9 27.6 24.7 7.3 2.7 0.7 31.9 27.5 25.1 9.4 18.4 14.7 40.2 6.7 21.1 9.4 13.7 39.3 11.9 8.5 4.7 20.9 9.0 23.5 13.2 37.6 57.5 30.4 30.8 6.9 26.1 7.1 24.0 21.2 11.0 1.7 34.8 23.3 20.2 0.3 14.9 3.6 0.3 7.6 1.5 10.6 22.3 30.8 24.5 4.0 58.0 20.8 11.4 18.4 15.0 10.5 18.8 1.8 10.7 7.5 16.1 6.9 15.5 7.0 18.9 11.5 25.9 19.9 22.3 26.4 25.1 20.6 27.7 27.1 0.4 25.5 16.2 19.2 23.6 16.7 13.2 17.4 8.9 9.5 10.3 11.1 13.3 7.2 10.3 9.3 26.8 25.1 23.1 44.0 16.3 13.3 158.2 86.6 121.8 59.1 34.9 11.8 242.5 363.1 46.4 49.2 44.3 33.7 46.7 154.5 15.1 57.4 23.5 22.0 167.8 55.4 17.5 50.1 41.7 22.4 39.8 58.7 24.7 33.7 36.1 38.2 54.7 71.1 41.2 47.7 504.9 43.8 25.8 23.7 25.7 33.2 11.2 85.2 49.0 60.0 20.4 FAR1 "FLJ22728, MLSTD2, SDR10E1" ENSG00000197601 "Fatty acyl-CoA reductase 1" Q8WVX9 11 13668670-13732346 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Cataract, Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Late spermatids: 125.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017322 Approved Supported Peroxisomes NA NA Peroxisomes "HPA017322: AB_1848424" "unprognostic (3.96e-2)" "unprognostic (1.92e-1)" "prognostic favorable (2.27e-4)" "unprognostic (1.38e-1)" "unprognostic (1.34e-1)" "unprognostic (4.62e-2)" "unprognostic (3.66e-1)" "unprognostic (3.30e-1)" "unprognostic (2.79e-1)" "unprognostic (3.60e-2)" "unprognostic (2.59e-2)" "unprognostic (1.84e-2)" "unprognostic (2.97e-2)" "unprognostic (2.52e-1)" "unprognostic (2.22e-1)" "unprognostic (2.22e-1)" "unprognostic (2.37e-3)" 16.3 11.1 19.0 14.2 28.2 42.7 13.7 24.4 24.0 17.3 20.9 33.8 11.1 24.7 17.4 17.1 38.1 12.7 9.2 13.9 20.4 16.1 9.7 3.3 13.9 12.2 32.8 24.0 16.7 15.8 25.1 16.5 15.8 30.0 14.1 25.1 10.0 14.6 10.9 11.4 8.0 13.4 20.2 47.8 13.9 39.4 12.8 32.2 13.2 13.2 17.2 15.0 16.7 22.1 2.8 15.8 21.8 13.7 5.0 4.5 4.0 27.0 17.7 17.5 13.6 16.8 19.4 9.6 24.2 9.7 17.9 19.1 18.5 23.4 34.8 10.9 19.3 26.7 29.6 25.8 24.5 27.6 10.2 21.0 14.9 16.1 0.1 16.2 29.8 12.1 14.7 25.3 12.9 38.9 13.3 17.5 17.7 23.2 10.4 14.7 13.7 22.0 9.0 9.1 34.5 25.7 19.5 22.4 9.7 17.3 44.0 13.5 9.8 22.9 21.9 11.9 21.1 13.4 18.7 21.7 24.8 21.1 22.7 20.2 5.8 19.8 29.5 15.7 9.1 14.9 4.6 13.7 15.0 4.5 11.9 3.1 2.1 2.2 3.8 15.8 2.8 2.0 3.4 21.8 5.0 9.4 2.4 2.8 4.0 19.0 28.2 24.4 24.0 20.4 16.1 32.8 24.0 30.0 32.2 32.8 19.7 8.2 20.6 28.6 44.7 23.2 5.1 9.4 21.6 21.0 39.3 21.4 5.0 12.6 98.3 26.3 45.7 23.3 22.2 15.2 24.6 24.0 38.1 1.6 29.3 44.5 34.5 35.0 52.6 125.1 24.7 35.6 33.7 16.2 26.0 22.1 23.3 37.4 24.1 7.0 50.8 25.8 27.8 36.7 26.8 17.3 8.2 16.6 38.8 32.4 GSTK1 GST13 ENSG00000197448 "Glutathione S-transferase kappa 1" Q9Y2Q3 7 143244093-143270854 "Enzymes, Plasma proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Late spermatids: 923.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA006311, HPA022904" Supported Supported Peroxisomes NA NA 1300000 Peroxisomes "HPA006311: AB_1849786, HPA022904: AB_1849787" "prognostic favorable (4.41e-6)" "unprognostic (2.40e-1)" "unprognostic (6.53e-2)" "unprognostic (4.49e-3)" "unprognostic (2.92e-2)" "unprognostic (1.15e-2)" "unprognostic (1.37e-1)" "unprognostic (2.99e-1)" "unprognostic (1.43e-1)" "unprognostic (3.76e-3)" "unprognostic (1.99e-2)" "unprognostic (7.27e-2)" "prognostic favorable (2.10e-6)" "unprognostic (2.66e-2)" "unprognostic (2.94e-1)" "unprognostic (9.13e-2)" "unprognostic (2.15e-2)" 38.0 45.3 14.0 45.3 19.9 29.0 43.0 5.6 19.6 30.4 69.0 19.9 35.7 58.0 24.8 39.8 37.8 27.4 55.2 56.4 15.0 13.1 67.6 97.1 35.4 52.2 24.3 16.3 22.7 39.9 46.2 20.7 41.5 23.9 28.0 43.5 34.4 72.9 35.8 38.9 30.0 91.0 22.2 17.5 58.5 34.8 18.9 20.8 27.1 48.0 56.6 50.3 29.4 26.6 32.8 57.1 35.7 75.4 22.3 99.0 95.2 27.3 19.7 2.8 24.6 43.6 62.7 13.1 16.2 27.8 14.5 29.0 11.9 70.3 15.6 23.1 23.4 21.9 41.6 10.8 25.3 12.7 30.0 11.7 12.7 14.8 18.6 30.1 15.3 20.8 56.5 31.2 16.7 11.9 21.7 38.5 20.5 17.8 19.1 38.8 21.1 15.6 27.8 6.5 53.4 29.9 13.5 0.4 30.8 50.2 15.1 11.4 15.6 29.7 48.4 24.6 17.7 23.3 21.5 22.7 7.9 7.3 20.6 13.7 32.7 15.3 3.5 28.6 61.8 16.2 35.7 67.9 25.8 41.1 74.8 39.6 32.8 76.4 52.4 57.1 21.9 39.5 38.1 21.2 22.3 75.4 23.9 99.0 95.2 14.0 19.9 5.6 19.6 15.0 13.1 24.3 16.3 23.9 20.8 65.5 100.3 104.0 135.2 101.4 10.8 146.0 216.6 120.5 84.2 115.1 11.8 257.6 247.1 119.7 471.4 96.3 424.2 23.3 105.8 108.4 95.9 76.6 140.9 263.3 268.7 7.9 147.4 136.2 267.9 923.0 67.3 177.0 143.4 164.1 202.4 80.8 97.6 394.4 47.7 486.1 13.7 84.1 117.9 6.2 8.8 101.8 153.7 238.2 288.1 173.8 HSD17B4 "DBP, MFE-2, SDR8C1" ENSG00000133835 "Hydroxysteroid 17-beta dehydrogenase 4" P51659 5 119452443-119637199 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Isomerase, Lyase, Oxidoreductase" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 203.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021302, HPA021311, HPA021479" Enhanced Enhanced Peroxisomes NA NA 6900000 Peroxisomes "HPA021302: AB_1844350, HPA021311: AB_1844351, HPA021479: AB_1844352" "unprognostic (1.03e-1)" "unprognostic (1.05e-1)" "prognostic favorable (1.33e-4)" "unprognostic (3.21e-2)" "unprognostic (1.24e-2)" "unprognostic (3.12e-2)" "unprognostic (2.83e-3)" "unprognostic (5.47e-2)" "unprognostic (1.54e-1)" "unprognostic (2.03e-2)" "unprognostic (1.02e-1)" "unprognostic (3.85e-1)" "prognostic favorable (6.31e-6)" "unprognostic (1.60e-1)" "unprognostic (8.26e-2)" "unprognostic (1.80e-1)" "unprognostic (6.65e-3)" 25.1 42.4 22.1 15.5 21.3 6.4 46.0 12.3 23.6 27.8 30.1 24.1 83.8 28.6 16.2 20.7 24.6 15.1 20.6 27.3 23.8 21.2 31.3 116.3 30.5 16.7 27.0 21.7 15.1 29.9 33.2 20.5 19.0 23.9 20.9 25.2 10.7 20.0 86.2 20.7 19.2 30.5 15.6 33.6 16.9 20.7 8.1 25.5 10.8 48.9 17.3 14.5 24.1 25.3 6.1 11.1 31.4 13.6 3.2 4.2 5.3 17.8 15.4 29.0 38.4 72.4 34.0 15.3 17.4 23.5 16.5 30.1 12.7 29.8 23.9 35.9 18.8 24.3 18.0 21.3 37.9 25.8 26.1 19.7 31.4 16.8 24.2 18.4 9.9 49.2 29.6 15.9 17.7 16.7 19.4 28.2 16.5 10.7 13.9 17.9 15.5 15.1 6.4 21.5 44.1 10.9 19.3 29.1 25.8 26.4 49.4 21.9 18.9 40.9 6.4 19.0 28.7 23.7 16.7 20.0 16.2 11.1 17.8 14.2 7.1 14.8 8.8 18.4 26.5 15.9 31.4 13.6 24.7 3.4 8.0 4.2 6.1 3.2 2.9 11.1 5.8 3.1 2.9 2.4 3.2 7.8 6.9 2.0 5.3 22.1 21.3 12.3 23.6 23.8 21.2 27.0 21.7 23.9 25.5 68.5 94.4 20.8 34.3 13.3 18.5 62.9 81.5 24.1 47.8 34.9 13.7 57.8 71.3 28.8 7.4 26.4 50.3 0.0 31.4 21.8 24.2 32.2 65.9 203.2 70.1 14.3 31.7 31.3 50.9 9.3 31.9 35.3 8.5 103.6 42.6 44.1 23.2 24.6 48.1 50.5 15.4 6.5 20.0 15.9 22.2 15.1 54.3 13.1 51.1 31.4 PECR "HSA250303, SDR29C1, TERP" ENSG00000115425 "Peroxisomal trans-2-enoyl-CoA reductase" Q9BY49 2 215996329-216082955 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 78.4" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 72.5;monocytes: 42.3;Proximal tubular cells: 49.9" "Cancer enhanced" "Detected in all" "liver cancer: 30.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 24.6;RPTEC TERT1: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021593, HPA022539" Enhanced Supported Peroxisomes NA NA Peroxisomes "HPA021593: AB_1855177, HPA022539: AB_1855178" "unprognostic (7.97e-2)" "unprognostic (1.08e-1)" "unprognostic (5.72e-2)" "unprognostic (1.32e-3)" "unprognostic (2.90e-1)" "unprognostic (6.40e-2)" "unprognostic (1.16e-3)" "unprognostic (3.56e-2)" "unprognostic (4.03e-2)" "unprognostic (1.11e-1)" "unprognostic (5.01e-3)" "unprognostic (5.61e-2)" "prognostic favorable (1.36e-5)" "unprognostic (6.63e-2)" "unprognostic (1.84e-2)" "unprognostic (7.75e-2)" "unprognostic (6.64e-2)" 14.2 4.4 3.2 6.5 3.3 3.5 7.0 6.7 3.7 2.8 11.5 4.4 2.7 13.2 2.0 6.6 2.4 4.5 7.2 2.7 3.3 3.1 17.4 78.4 3.6 3.8 4.4 2.9 3.2 3.1 3.8 5.4 0.9 3.5 3.1 4.2 6.2 3.5 3.5 3.4 3.3 20.9 3.2 5.1 2.8 2.6 0.9 3.6 2.4 8.5 2.0 3.5 2.2 4.1 5.1 1.4 4.1 3.9 8.8 14.7 4.1 3.8 4.3 1.7 0.1 10.6 3.9 2.1 0.9 2.1 2.5 4.2 4.9 11.2 0.1 8.0 2.3 6.2 0.9 4.7 5.7 4.4 6.1 5.1 5.0 2.5 24.6 10.7 1.3 3.5 3.3 4.0 2.6 3.7 3.8 2.4 3.0 2.1 5.7 5.4 2.8 1.5 1.4 3.2 0.0 3.2 3.4 3.3 0.5 23.8 0.6 2.4 3.5 2.3 4.9 9.7 4.4 5.8 4.2 0.0 1.6 1.7 4.0 2.8 6.7 5.6 2.0 3.6 1.8 3.7 0.8 3.9 1.3 6.4 1.5 7.3 4.2 8.6 7.3 1.4 5.1 9.2 6.0 4.1 8.8 2.0 0.2 14.7 4.1 3.2 3.3 6.7 3.7 3.3 3.1 4.4 2.9 3.5 3.6 6.0 9.9 3.7 3.8 3.3 10.0 3.1 35.7 9.4 2.3 27.9 13.7 3.5 11.6 10.3 0.1 3.3 12.7 0.0 3.4 6.4 3.5 1.9 1.1 72.5 8.0 3.2 6.9 7.4 2.8 0.0 5.2 5.9 10.1 42.3 6.5 7.8 4.3 17.5 7.8 49.9 6.4 0.0 4.2 0.0 1.8 2.5 1.4 8.7 13.3 1.4 PEX1 "ZWS, ZWS1" ENSG00000127980 "Peroxisomal biogenesis factor 1" O43933 7 92487020-92528531 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Peroxisome biogenesis, Protein transport, Transport" "Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020235 Approved Supported Peroxisomes NA NA Peroxisomes "HPA020235: AB_1855224" "unprognostic (4.67e-2)" "unprognostic (2.23e-1)" "unprognostic (1.55e-2)" "unprognostic (1.53e-2)" "unprognostic (4.85e-1)" "unprognostic (2.41e-2)" "unprognostic (7.81e-2)" "unprognostic (9.79e-3)" "unprognostic (2.17e-2)" "unprognostic (6.39e-2)" "unprognostic (1.68e-2)" "unprognostic (3.61e-2)" "unprognostic (2.95e-3)" "unprognostic (1.59e-1)" "unprognostic (2.49e-1)" "unprognostic (5.35e-3)" "unprognostic (4.90e-2)" 11.3 13.8 8.9 13.1 19.1 5.8 14.0 14.3 14.7 12.7 13.2 15.8 19.0 10.2 12.2 18.7 13.0 9.5 10.6 13.4 9.5 9.3 22.4 20.3 8.4 9.9 15.4 9.3 14.3 17.5 23.3 22.5 8.0 18.5 12.9 15.4 13.7 13.6 20.6 16.1 15.0 12.7 12.2 15.0 10.2 12.9 10.2 13.6 15.2 13.8 14.6 11.1 11.5 11.6 5.5 2.1 3.1 3.6 7.9 6.2 1.9 5.7 6.3 10.4 17.6 6.6 5.6 9.4 3.8 5.0 4.6 6.6 3.8 6.1 8.5 8.7 4.4 7.0 5.9 7.9 6.9 7.3 8.8 7.0 4.1 6.8 4.8 4.6 7.3 4.6 6.1 6.3 6.8 9.3 5.7 7.1 8.9 15.0 12.2 7.1 10.8 14.5 7.1 7.2 8.4 5.9 10.3 11.6 10.6 6.4 8.5 7.7 12.4 8.8 24.6 7.5 15.1 5.0 3.1 5.8 4.4 6.0 16.6 4.0 13.7 10.8 11.8 4.1 4.3 7.0 1.1 2.0 3.1 4.7 3.2 4.6 5.5 4.9 5.1 2.1 4.7 5.7 6.2 1.6 7.9 3.6 1.3 4.6 1.9 8.9 19.1 14.3 14.7 9.5 9.3 15.4 9.3 18.5 13.6 26.8 13.6 5.7 7.2 5.3 42.4 25.0 2.5 41.5 12.5 5.2 33.4 7.5 8.3 5.6 4.8 8.7 15.1 23.3 6.5 3.1 5.2 8.0 8.1 11.6 4.7 38.1 13.4 8.6 9.4 3.8 13.3 5.6 6.8 13.6 12.9 16.6 5.7 13.6 14.2 15.3 45.7 6.5 6.1 28.4 10.4 6.8 7.0 8.7 13.3 7.0 PEX13 ENSG00000162928 "Peroxisomal biogenesis factor 13" Q92968 2 61017225-61051990 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032141, HPA032142, CAB032689" Enhanced Supported Peroxisomes NA NA Peroxisomes "CAB032689: AB_2162137, HPA032141: AB_2674176, HPA032142: AB_10669676" "unprognostic (2.44e-3)" "unprognostic (4.10e-2)" "unprognostic (7.84e-3)" "unprognostic (2.73e-2)" "unprognostic (1.28e-1)" "unprognostic (5.08e-2)" "unprognostic (2.05e-2)" "unprognostic (1.78e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-2)" "prognostic unfavorable (8.07e-5)" "unprognostic (5.42e-2)" "unprognostic (4.44e-2)" "unprognostic (1.93e-1)" "unprognostic (2.84e-1)" "unprognostic (1.41e-1)" "unprognostic (2.63e-2)" 11.7 11.5 14.2 9.1 14.7 8.4 29.2 21.4 14.9 14.3 13.1 10.3 6.0 13.0 12.3 10.3 15.7 8.9 11.6 16.3 14.1 11.7 17.7 31.8 16.8 13.1 11.7 11.7 16.5 19.5 10.9 18.7 11.9 10.8 19.6 14.1 11.6 13.7 8.7 20.7 11.5 15.3 17.4 12.2 8.2 12.7 18.2 12.3 11.7 18.0 9.7 11.0 13.7 13.3 8.3 7.9 15.1 7.0 8.0 10.5 6.2 10.4 7.7 11.1 14.2 10.6 8.4 17.1 10.9 8.6 7.5 7.7 11.5 15.9 6.8 11.9 10.7 14.1 15.8 9.8 13.2 14.2 6.6 6.8 6.3 10.4 19.0 12.6 9.3 7.7 10.2 20.4 10.2 15.8 11.5 13.5 7.8 15.1 6.1 11.3 9.5 6.9 11.2 12.0 19.4 7.8 7.4 12.2 8.6 14.2 26.2 12.5 8.6 12.2 16.7 9.8 13.7 11.1 4.9 10.5 14.4 19.2 8.3 9.3 10.0 7.7 17.2 9.1 9.6 10.1 15.1 6.1 8.8 8.3 5.8 7.9 8.3 9.7 9.2 7.9 6.7 10.5 7.9 6.0 8.0 7.0 7.0 8.2 6.2 14.2 14.7 21.4 14.9 14.1 11.7 11.7 11.7 10.8 12.3 17.9 15.5 20.1 29.3 45.4 11.5 17.5 22.9 22.7 21.6 21.0 7.9 33.0 21.6 24.5 86.1 14.6 23.6 0.0 24.5 33.0 13.4 37.4 8.1 40.0 18.9 15.9 2.4 12.3 12.1 19.4 8.9 19.0 15.1 24.4 13.1 11.4 23.4 15.8 11.0 25.0 13.8 6.5 16.7 40.9 19.0 44.0 57.4 17.3 16.3 77.9 PEX14 ENSG00000142655 "Peroxisomal biogenesis factor 14" O75381 1 10472288-10630758 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 60.6;Syncytiotrophoblasts: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046104, HPA049231" Supported Supported "Nucleoli fibrillar center,Peroxisomes" NA NA Peroxisomes "Nucleoli fibrillar center" "HPA046104: AB_2679539, HPA049231: AB_2680683" "unprognostic (7.23e-3)" "unprognostic (7.93e-2)" "unprognostic (3.50e-2)" "unprognostic (1.48e-2)" "unprognostic (3.66e-1)" "unprognostic (1.61e-1)" "unprognostic (1.43e-1)" "unprognostic (1.77e-1)" "unprognostic (5.32e-2)" "unprognostic (2.32e-1)" "unprognostic (5.85e-2)" "unprognostic (1.31e-1)" "unprognostic (3.05e-3)" "unprognostic (9.67e-3)" "unprognostic (1.37e-1)" "unprognostic (1.43e-1)" "unprognostic (3.75e-2)" 14.9 11.6 14.3 12.2 22.3 8.3 13.1 15.7 35.0 11.8 14.8 18.6 8.3 18.0 14.4 10.4 22.6 14.8 12.2 17.8 14.4 16.2 13.3 25.9 13.6 11.6 13.0 16.1 15.7 15.3 13.6 14.2 17.7 22.4 21.9 10.5 14.8 20.0 31.0 22.1 14.6 20.9 10.7 11.1 11.2 12.8 18.7 11.4 11.4 13.5 11.6 17.3 38.7 13.6 4.2 5.0 7.3 3.8 4.2 8.4 3.6 15.6 14.8 12.6 13.8 9.3 8.8 8.2 18.1 15.3 20.2 19.3 15.6 29.1 11.4 18.1 13.8 12.0 18.7 13.1 17.4 9.7 16.0 21.4 14.0 16.1 21.3 14.0 15.8 20.2 10.6 14.1 15.3 14.1 12.1 12.9 15.1 21.9 11.8 9.1 12.9 15.1 20.8 12.9 12.3 17.4 16.4 10.5 16.3 15.9 10.4 15.0 17.2 17.5 14.7 16.3 10.2 13.5 11.4 12.4 14.8 15.6 14.3 15.3 17.0 13.8 22.3 16.2 21.9 15.7 1.9 3.8 7.3 8.4 2.8 5.3 4.2 4.4 6.2 4.7 3.9 5.8 5.2 0.6 4.2 2.5 5.0 5.2 3.6 14.3 22.3 15.7 35.0 14.4 16.2 13.0 16.1 22.4 11.4 8.9 1.3 7.5 12.5 6.4 14.7 6.1 5.1 21.4 2.3 8.7 25.5 40.0 6.6 15.0 2.2 6.0 18.7 0.0 12.7 15.4 7.1 9.7 5.8 48.3 20.4 17.5 8.6 9.8 7.9 2.4 7.5 5.9 11.8 32.5 8.4 13.8 14.7 10.5 5.3 14.8 60.6 6.5 7.2 5.9 12.1 7.0 54.1 8.5 10.5 11.2 PEX19 "D1S2223E, HK33, PMP1, PMPI, PXF, PXMP1" ENSG00000162735 "Peroxisomal biogenesis factor 19" P40855 1 160276812-160286348 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Peroxisome biogenesis" "Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044837, HPA051966" Supported Supported Peroxisomes NA NA Peroxisomes "HPA044837: AB_10962496, HPA051966: AB_2681677" "unprognostic (1.49e-2)" "unprognostic (2.26e-1)" "unprognostic (3.42e-1)" "unprognostic (4.80e-3)" "unprognostic (3.89e-2)" "unprognostic (3.88e-2)" "unprognostic (3.79e-1)" "unprognostic (1.51e-1)" "unprognostic (2.32e-1)" "unprognostic (1.53e-2)" "unprognostic (8.06e-2)" "unprognostic (1.00e-1)" "prognostic favorable (2.92e-5)" "unprognostic (3.46e-2)" "unprognostic (2.25e-1)" "unprognostic (2.19e-2)" "unprognostic (1.24e-2)" 41.9 20.4 21.5 8.0 27.8 6.2 24.4 10.0 30.6 12.5 12.9 23.8 8.9 11.0 13.0 15.0 14.6 13.6 11.3 21.7 18.5 21.0 19.5 61.6 12.2 8.7 20.3 17.2 14.5 12.6 17.5 14.3 15.0 25.0 16.8 13.8 17.8 16.2 16.3 32.9 14.1 12.7 10.0 17.4 11.8 12.7 11.4 12.9 9.1 22.2 12.1 11.3 13.4 8.7 9.7 13.0 11.8 15.6 6.9 10.2 7.5 12.4 7.6 29.5 9.1 25.2 24.9 22.2 10.2 21.1 19.0 15.1 14.0 15.3 15.4 17.5 15.5 11.1 12.2 14.1 18.4 15.0 13.3 7.0 10.7 10.8 14.3 20.6 19.4 13.6 37.3 21.3 25.7 16.5 15.3 13.3 21.3 16.1 11.9 21.3 6.9 14.5 6.3 21.0 15.9 20.1 18.4 14.5 18.3 19.2 25.3 9.6 16.0 40.8 20.7 15.4 31.6 20.2 19.1 10.1 11.0 13.2 12.5 12.1 17.7 22.7 28.0 18.2 8.4 16.2 9.2 12.2 11.8 10.2 15.6 8.3 9.7 5.9 7.2 13.0 5.6 7.5 6.8 4.8 6.9 10.2 6.3 8.7 7.5 21.5 27.8 10.0 30.6 18.5 21.0 20.3 17.2 25.0 12.9 8.9 19.4 9.8 17.0 8.9 18.7 41.6 20.4 10.7 5.7 15.7 9.8 24.5 41.4 18.8 4.2 13.2 23.3 0.0 12.9 43.8 15.3 16.7 16.1 52.9 26.1 23.8 10.9 20.3 12.7 2.2 20.1 13.5 20.3 31.5 14.5 30.7 16.8 19.0 27.6 34.2 9.6 32.3 17.8 13.9 25.9 8.7 32.4 14.4 15.5 19.0 PEX3 ENSG00000034693 "Peroxisomal biogenesis factor 3" P56589 6 143450807-143490010 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 65.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042830, HPA058006" Supported Approved Nucleoplasm,Peroxisomes NA NA "Nucleoplasm, Peroxisomes" "HPA042830: AB_10794918, HPA058006: AB_2683576" "unprognostic (3.52e-3)" "unprognostic (6.28e-2)" "unprognostic (1.81e-2)" "unprognostic (1.51e-2)" "unprognostic (1.21e-1)" "unprognostic (4.16e-1)" "unprognostic (8.45e-2)" "unprognostic (1.19e-1)" "unprognostic (1.09e-1)" "unprognostic (1.56e-2)" "unprognostic (2.50e-2)" "unprognostic (2.16e-1)" "prognostic favorable (3.80e-4)" "unprognostic (1.87e-1)" "unprognostic (7.30e-2)" "unprognostic (3.80e-2)" "unprognostic (2.12e-1)" 10.1 47.5 13.7 14.0 15.5 3.3 14.5 17.3 17.7 13.6 8.5 12.1 14.0 7.0 12.5 16.4 21.1 12.5 9.0 15.8 14.3 11.4 22.7 29.2 9.6 10.3 13.7 15.9 14.4 8.6 16.2 14.8 22.2 17.4 15.0 8.1 10.4 12.8 15.7 12.6 14.6 8.8 12.7 14.6 8.7 11.3 14.4 12.7 10.1 19.3 13.5 11.6 11.9 15.1 18.2 8.7 7.8 9.6 12.0 18.7 8.1 14.6 3.6 7.7 16.1 12.8 12.6 9.6 13.1 10.7 18.2 22.2 23.6 9.5 25.6 15.6 14.0 19.6 12.4 10.6 18.6 22.5 14.8 13.0 18.1 7.4 15.2 11.8 29.1 7.3 15.3 12.7 17.4 13.1 8.6 9.9 13.3 15.4 11.8 17.3 10.2 14.7 11.8 4.9 8.9 13.1 11.3 17.3 11.0 22.3 6.3 11.9 4.3 17.4 15.1 11.6 7.8 7.6 9.7 9.1 13.0 11.1 22.2 15.5 8.5 10.7 25.6 17.0 20.1 10.2 7.8 5.1 4.9 13.2 8.0 15.1 18.2 14.1 13.1 7.9 15.4 18.7 17.9 0.8 12.0 9.6 8.7 16.5 8.1 13.7 15.5 17.3 17.7 14.3 11.4 13.7 15.9 17.4 12.7 14.9 11.8 10.0 10.4 23.7 12.3 11.3 5.1 25.4 14.8 8.7 3.9 32.3 16.6 11.5 3.2 11.7 5.5 0.0 8.3 9.5 12.0 7.4 24.3 18.1 9.9 15.9 5.8 12.9 7.5 3.2 12.7 6.4 8.5 9.0 5.0 14.1 7.5 2.9 10.6 19.9 11.9 6.5 14.1 65.4 17.0 30.5 49.1 8.7 7.0 5.9 PLIN1 PLIN ENSG00000166819 "Perilipin 1" O60240 15 89664365-89679427 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "adipose tissue: 187.5;breast: 62.6" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 49.1" "Cancer enhanced" "Detected in many" "breast cancer: 8.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 176 "ASC diff: 70.4" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA024299, CAB033821, CAB037333" Enhanced Uncertain Peroxisomes NA NA 8900 Peroxisomes "CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467" "unprognostic (4.62e-2)" "unprognostic (2.22e-1)" "unprognostic (2.13e-1)" "unprognostic (1.67e-1)" "unprognostic (1.90e-1)" "unprognostic (3.51e-3)" "unprognostic (9.89e-3)" "unprognostic (3.54e-1)" "unprognostic (7.01e-2)" "unprognostic (2.13e-2)" "unprognostic (8.00e-3)" "unprognostic (2.28e-3)" "unprognostic (2.62e-6)" "unprognostic (5.56e-2)" "unprognostic (1.22e-1)" "unprognostic (1.63e-1)" "unprognostic (4.85e-2)" 187.5 2.6 1.8 7.1 1.3 0.3 62.6 0.8 0.8 0.3 10.6 1.6 0.4 0.4 0.3 1.9 0.5 0.4 7.4 8.3 2.7 0.6 0.6 5.8 0.3 2.8 0.8 1.5 0.4 1.4 0.3 0.1 0.3 1.0 0.4 1.1 0.0 7.6 1.5 7.2 2.2 2.2 0.6 0.4 0.3 0.5 1.6 1.8 0.0 0.7 8.0 0.3 1.5 1.5 0.0 0.0 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 70.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.8 1.3 0.8 0.7 2.7 0.6 0.8 1.5 1.0 1.8 0.0 0.0 0.0 0.2 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.0 49.1 0.0 0.0 0.0 1.8 1.3 4.9 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 5.4 0.2 0.4 0.0 0.0 0.0 0.7 PRRT4 ENSG00000224940 "Proline rich transmembrane protein 4" C9JH25 7 128350325-128361685 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 49.0" "Cell type enriched" "Detected in some" 8 "Horizontal cells: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 72.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA046373, HPA052681" Uncertain Approved "Nucleoplasm,Peroxisomes,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Peroxisomes, Plasma membrane" "HPA046373: AB_2679642, HPA052681: AB_2681912" "unprognostic (1.72e-1)" "unprognostic (4.55e-2)" "unprognostic (5.36e-3)" "unprognostic (1.20e-4)" "unprognostic (2.60e-1)" "unprognostic (7.81e-2)" "unprognostic (1.88e-1)" "unprognostic (1.56e-1)" "unprognostic (5.62e-3)" "unprognostic (1.61e-1)" "unprognostic (2.48e-4)" "unprognostic (9.11e-2)" "unprognostic (3.73e-4)" "unprognostic (5.28e-3)" "unprognostic (9.09e-2)" "unprognostic (1.22e-2)" "unprognostic (1.27e-2)" 12.1 1.9 2.0 5.9 11.3 49.0 6.8 6.5 3.1 1.6 2.7 0.6 0.0 0.6 0.7 0.5 1.9 1.0 1.1 2.4 1.7 6.2 0.5 0.7 0.8 0.6 1.6 2.4 1.0 0.6 0.8 0.0 0.6 2.9 0.8 0.7 3.4 1.9 1.3 4.2 1.5 0.8 1.0 2.8 1.3 1.6 0.7 1.5 0.7 0.7 1.7 1.0 2.0 3.2 0.0 0.4 0.4 0.4 0.0 1.5 0.4 0.0 0.0 0.1 0.1 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 2.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.3 0.7 14.1 0.3 0.0 0.0 3.9 0.2 0.3 0.0 0.0 0.1 72.0 0.1 0.0 0.1 0.5 0.0 1.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.2 0.5 0.0 0.0 1.5 0.7 0.4 0.0 0.0 0.4 0.0 0.4 2.0 11.3 6.5 3.1 1.7 6.2 1.6 2.4 2.9 1.5 0.0 0.0 0.0 0.0 0.6 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 9.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.4 0.3 0.2 0.0 0.0 0.0 PXMP4 PMP24 ENSG00000101417 "Peroxisomal membrane protein 4" Q9Y6I8 20 33702754-33720319 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 61.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 19.6;SK-BR-3: 35.9;T-47d: 30.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050077 Approved Approved "Nucleoli fibrillar center,Peroxisomes" NA NA Peroxisomes "Nucleoli fibrillar center" "HPA050077: AB_2681006" "unprognostic (3.41e-2)" "unprognostic (1.11e-1)" "unprognostic (2.59e-1)" "unprognostic (1.75e-1)" "unprognostic (5.08e-2)" "unprognostic (1.30e-2)" "unprognostic (1.17e-1)" "prognostic favorable (3.88e-4)" "unprognostic (3.53e-1)" "unprognostic (4.47e-2)" "unprognostic (4.32e-2)" "unprognostic (1.86e-1)" "prognostic favorable (4.03e-10)" "unprognostic (3.84e-2)" "unprognostic (2.20e-1)" "unprognostic (6.08e-2)" "unprognostic (2.20e-1)" 6.2 20.0 6.4 5.4 10.0 3.9 15.6 4.7 12.6 7.8 7.8 12.5 16.9 10.1 7.1 7.1 10.0 8.0 9.1 7.9 6.7 5.3 6.7 13.4 27.5 9.3 6.1 9.2 9.2 9.5 24.4 5.3 5.0 6.5 11.5 7.5 10.8 27.6 13.2 9.9 14.4 11.8 7.1 7.6 6.4 9.0 4.2 5.9 8.4 19.0 6.9 5.9 10.6 9.0 6.2 6.2 12.0 21.9 5.8 8.5 5.5 1.2 5.6 1.6 5.6 2.8 4.1 4.0 4.0 2.2 3.1 1.4 19.6 6.2 0.0 7.8 3.4 7.7 5.9 4.2 4.7 2.2 1.6 1.6 6.4 4.8 0.1 2.6 0.3 4.9 3.1 5.1 4.3 1.4 1.6 2.0 2.0 3.5 4.1 2.2 12.0 5.8 4.5 0.2 9.9 0.0 3.1 7.7 0.7 2.0 4.1 5.1 2.6 11.3 35.9 3.6 0.9 30.3 2.1 4.0 2.3 2.6 5.7 3.7 2.6 5.8 0.1 4.4 2.1 3.8 1.4 8.0 12.0 8.1 14.9 8.5 5.5 8.3 8.1 6.2 6.2 6.3 8.5 2.1 5.8 21.9 3.8 5.7 5.5 6.4 10.0 4.7 12.6 6.7 5.3 6.1 9.2 6.5 5.9 17.9 61.7 5.2 4.0 1.4 9.9 11.3 12.7 6.7 21.6 17.4 13.7 10.3 8.3 7.1 24.5 6.6 15.1 0.0 8.6 20.0 6.1 4.1 3.5 27.9 13.0 4.8 4.1 8.6 6.7 30.4 9.8 5.0 3.3 4.6 10.9 15.3 6.3 10.5 10.6 7.7 10.2 6.5 4.2 2.3 8.9 2.0 3.7 3.5 12.4 3.5 SCP2 ENSG00000116171 "Sterol carrier protein 2" P22307 1 52927229-53051703 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid transport, Transport" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 168.3" "Cell type enhanced" "Detected in all" 6 "Hepatocytes: 1150.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027101, HPA027135, HPA027317" Supported Supported Nucleoplasm,Peroxisomes NA NA 370000 Peroxisomes Nucleoplasm "HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422" "unprognostic (7.51e-2)" "unprognostic (5.23e-2)" "prognostic favorable (7.05e-5)" "unprognostic (9.68e-2)" "unprognostic (1.53e-2)" "unprognostic (5.53e-2)" "unprognostic (1.87e-3)" "unprognostic (1.22e-2)" "unprognostic (1.62e-2)" "unprognostic (1.59e-1)" "unprognostic (4.53e-2)" "unprognostic (6.16e-2)" "prognostic favorable (7.85e-8)" "unprognostic (1.49e-2)" "unprognostic (1.09e-1)" "unprognostic (8.64e-2)" "unprognostic (1.13e-2)" 29.1 26.2 21.8 19.9 21.2 14.0 30.3 12.0 19.7 24.4 51.9 15.9 28.1 49.2 19.0 28.8 32.2 18.1 32.1 29.3 20.0 20.0 54.2 168.3 21.8 14.0 25.6 17.8 22.8 24.6 16.7 24.1 17.1 21.9 25.5 40.5 18.9 21.8 23.3 22.0 18.8 80.1 20.6 27.1 20.9 33.9 16.7 19.4 23.0 28.2 28.6 17.6 22.3 20.5 36.4 57.1 67.8 50.7 40.8 49.2 61.2 25.6 14.1 19.0 34.8 62.4 53.4 20.6 30.6 45.9 20.1 29.2 12.6 27.8 24.4 33.1 44.8 23.5 18.0 13.0 28.6 30.8 35.5 18.9 26.2 20.3 25.9 41.6 37.7 44.2 43.3 39.0 23.8 11.9 44.1 56.9 28.9 23.3 12.7 40.6 14.8 42.0 32.8 20.8 65.1 27.7 22.0 33.5 33.3 55.8 43.6 15.7 19.0 26.7 54.2 25.6 44.1 27.7 43.2 44.0 27.4 14.2 47.7 24.4 21.3 27.0 28.5 35.5 37.5 25.3 55.4 48.7 67.8 49.2 50.7 39.9 36.4 39.2 48.6 57.1 29.8 33.2 47.1 7.5 40.8 46.8 37.1 47.1 61.2 21.8 21.2 12.0 19.7 20.0 20.0 25.6 17.8 21.9 19.4 125.0 163.3 99.5 107.7 133.6 35.0 136.8 201.2 147.2 103.5 176.2 29.5 158.8 401.3 140.3 42.8 125.8 592.0 70.0 143.6 134.4 129.4 170.2 138.2 1150.9 181.7 39.7 225.9 115.4 211.6 39.0 170.6 166.5 182.2 152.3 388.8 98.9 131.8 498.1 161.5 617.2 27.0 77.6 119.7 10.6 19.8 149.3 112.0 172.0 297.8 155.6 SLC25A17 PMP34 ENSG00000100372 "Solute carrier family 25 member 17" O43808 22 40769630-40819399 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052708, HPA060972" Approved Supported Peroxisomes NA NA Peroxisomes "HPA052708: AB_2681924, HPA060972: AB_2684400" "unprognostic (2.75e-1)" "unprognostic (1.11e-3)" "unprognostic (1.91e-3)" "unprognostic (2.44e-2)" "unprognostic (2.61e-1)" "unprognostic (1.96e-2)" "unprognostic (2.85e-3)" "unprognostic (2.16e-1)" "unprognostic (1.72e-1)" "unprognostic (1.63e-3)" "unprognostic (8.44e-2)" "unprognostic (2.72e-1)" "unprognostic (5.59e-2)" "unprognostic (8.54e-2)" "unprognostic (1.55e-1)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" 9.7 15.0 10.2 10.2 10.9 3.3 16.8 12.9 14.1 11.8 7.2 12.2 7.5 6.4 22.4 22.6 8.7 13.7 7.4 5.5 10.4 13.4 18.6 19.7 9.0 11.8 10.3 7.7 26.5 12.4 14.3 13.0 14.9 11.9 12.6 8.7 9.5 11.4 10.3 4.6 10.9 7.1 12.1 11.4 8.8 8.9 12.1 9.5 12.6 14.7 10.4 11.2 7.1 8.7 10.2 6.8 5.9 4.9 10.3 11.7 6.4 13.4 7.4 12.6 11.0 8.0 9.7 10.3 12.2 13.4 19.5 21.5 10.8 5.1 15.9 7.5 12.0 11.1 10.8 18.3 10.1 20.0 16.3 24.5 17.8 11.5 11.1 11.3 20.5 9.5 9.6 13.5 17.2 11.1 9.0 11.8 13.3 25.7 7.6 15.8 11.5 12.3 13.2 10.6 19.1 12.3 13.5 19.6 23.2 16.1 11.4 8.7 7.9 25.2 15.5 15.0 12.8 12.9 6.1 6.9 11.0 15.1 9.7 11.0 8.4 16.3 15.1 12.0 10.4 11.9 5.9 4.4 5.1 7.0 4.9 9.2 10.2 8.1 7.5 5.7 9.5 11.7 9.3 1.8 10.3 3.9 6.8 10.8 6.4 10.2 10.9 12.9 14.1 10.4 13.4 10.3 7.7 11.9 9.5 17.9 7.4 10.7 13.0 14.7 11.7 3.1 7.6 12.0 17.0 12.2 7.9 34.1 18.3 16.2 6.5 9.3 6.3 0.0 15.3 27.0 16.0 15.6 4.7 21.2 11.5 11.1 5.8 5.5 7.3 8.5 25.0 7.6 15.1 25.2 3.3 10.6 14.6 5.8 25.1 15.9 7.0 32.3 10.8 37.1 36.6 15.1 23.9 10.0 7.7 13.3 TMEM41B KIAA0033 ENSG00000166471 "Transmembrane protein 41B" Q5BJD5 11 9280654-9314780 "Predicted membrane proteins" "Autophagy, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CAPAN-2: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014946 Uncertain Approved Peroxisomes NA NA Peroxisomes "HPA014946: AB_2205037" "unprognostic (1.21e-1)" "unprognostic (2.19e-1)" "unprognostic (1.35e-1)" "unprognostic (2.75e-3)" "unprognostic (5.78e-3)" "unprognostic (1.94e-1)" "prognostic unfavorable (9.18e-6)" "unprognostic (6.18e-2)" "unprognostic (9.37e-3)" "unprognostic (4.90e-3)" "unprognostic (1.36e-2)" "unprognostic (4.02e-2)" "unprognostic (1.29e-1)" "unprognostic (1.40e-1)" "unprognostic (2.20e-1)" "unprognostic (3.55e-2)" "unprognostic (8.18e-2)" 9.2 11.6 11.9 8.7 13.0 15.5 10.5 13.7 17.6 8.0 14.3 20.1 15.6 21.8 7.3 10.6 13.5 7.8 10.5 10.7 11.9 14.6 14.6 23.0 19.3 9.5 16.2 12.9 9.1 14.6 18.8 13.4 13.8 20.1 14.0 11.3 10.1 11.8 11.1 8.8 15.9 21.2 5.9 13.5 10.2 15.5 14.9 14.6 14.9 21.3 8.5 11.0 9.6 8.8 7.2 6.0 8.0 2.4 7.1 9.2 3.7 13.1 13.8 7.8 6.7 7.6 11.1 18.7 11.8 11.3 7.0 12.9 6.6 42.8 5.7 11.0 7.5 10.5 17.3 9.0 7.1 8.7 9.8 6.9 4.6 9.3 6.8 9.9 4.2 6.5 9.4 10.2 6.7 8.4 6.0 5.9 6.4 9.9 14.4 13.5 4.7 6.8 1.8 24.0 7.8 7.2 4.6 10.8 7.9 10.8 13.2 2.4 8.5 11.8 9.9 8.2 9.1 8.8 6.6 8.2 7.7 9.0 11.9 6.1 4.6 7.1 10.3 8.6 2.7 6.4 6.3 1.9 7.4 4.7 1.6 4.3 7.2 4.4 5.1 3.1 5.9 9.2 7.6 8.0 7.1 2.4 6.0 4.0 3.7 11.9 13.0 13.7 17.6 11.9 14.6 16.2 12.9 20.1 14.6 44.7 63.2 19.3 50.5 67.5 35.1 20.2 38.2 20.1 33.0 29.6 62.8 39.2 6.6 23.1 1.2 17.5 47.2 23.3 34.4 43.5 26.9 51.9 16.2 46.5 19.9 19.1 38.1 19.6 16.5 1.4 16.7 20.5 18.6 27.1 37.0 25.3 41.4 28.5 13.1 18.2 37.4 19.4 24.2 39.0 41.7 55.7 46.9 20.6 29.6 53.6